These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37756247)

  • 21. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Ultrasound in the Evaluation of Neonatal Respiratory Distress Syndrome.
    Xin H; Wang L; Hao W; Hu H; Li H; Liu B
    J Ultrasound Med; 2023 Feb; 42(3):713-721. PubMed ID: 36106717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant therapy for neonatal respiratory distress syndrome: a review of Korean experiences over 17 years.
    Bae CW; Hahn WH
    J Korean Med Sci; 2009 Dec; 24(6):1110-8. PubMed ID: 19949668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
    Network of Northwest Neonatal Professional Collaboration Group
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of ultrasonography for respiratory distress syndrome in neonates.
    Bober K; Swietliński J
    Med Sci Monit; 2006 Oct; 12(10):CR440-6. PubMed ID: 17006405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound diagnosis and grading criteria of neonatal respiratory distress syndrome.
    Liu J
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2206943. PubMed ID: 37142428
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of pulmonary surfactant on Th1/Th2 balance in neonates with respiratory distress syndrome].
    Zhai SF; Liu CQ; Ping LL; Tian BL
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):893-7. PubMed ID: 23234772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
    Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early lung ultrasound score to predict noninvasive ventilation needing in neonates from 33 weeks of gestational age: A multicentric study.
    Perri A; Sbordone A; Patti ML; Nobile S; Tirone C; Giordano L; Tana M; D'Andrea V; Priolo F; Serrao F; Riccardi R; Prontera G; Maddaloni C; Lenkowicz J; Boldrini L; Vento G
    Pediatr Pulmonol; 2022 Sep; 57(9):2227-2236. PubMed ID: 35670034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE; Pai MG; Al Khusaiby SM
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome].
    Gao Y; Chen X; Zhang Z; Qu S; Sang X; Wu Y; Zhou R; Peng W; Chen Y; Wang Y; Zhuo F; Chen L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):80-84. PubMed ID: 35307066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung ultrasound for early surfactant treatment: Development and validation of a predictive model.
    Aldecoa-Bilbao V; Balcells-Esponera C; Herranz Barbero A; Borràs-Novell C; Izquierdo Renau M; Iriondo Sanz M; Salvia Roigés M
    Pediatr Pulmonol; 2021 Feb; 56(2):433-441. PubMed ID: 33369257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.